The following data is part of a premarket notification filed by Diasorin, Inc. with the FDA for Modification To Copalis Cmv Total Antibody Assay.
Device ID | K982027 |
510k Number | K982027 |
Device Name: | MODIFICATION TO COPALIS CMV TOTAL ANTIBODY ASSAY |
Classification | Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus |
Applicant | DIASORIN, INC. 9175 GUIFORD RD. Columbia, MD 21046 |
Contact | Judith J Smith |
Correspondent | Judith J Smith DIASORIN, INC. 9175 GUIFORD RD. Columbia, MD 21046 |
Product Code | LFZ |
CFR Regulation Number | 866.3175 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 1998-06-02 |
Decision Date | 1998-11-25 |
Summary: | summary |